NEW YORK (GenomeWeb News) – Pressure BioSciences has been awarded a grant of $110,000 from the National Institutes of Health for its pressure cycling technology, the company said today.

The Small Business Innovation Research grant, from the National Institute on Allergy and Infectious Diseases, is focused on funding development of sample preparation technology using pressure for microbiome studies and for clinical diagnostics. The company said that the research calls for PCT to be used to prepare all of the samples for the study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Dec
14
Sponsored by
N-of-one

About one year ago, the Association for Molecular Pathology (AMP), with liaison representation from the American College of Medical Genetics and Genomics (ACMG), American Society of Clinical Oncology (ASCO), and College of American Pathologists (CAP), released a guideline on reporting somatic cancer variants.